1-154841792-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002249.6(KCNN3):​c.934-19608C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.298 in 152,154 control chromosomes in the GnomAD database, including 7,161 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.30 ( 7161 hom., cov: 32)

Consequence

KCNN3
NM_002249.6 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.556

Publications

52 publications found
Variant links:
Genes affected
KCNN3 (HGNC:6292): (potassium calcium-activated channel subfamily N member 3) Action potentials in vertebrate neurons are followed by an afterhyperpolarization (AHP) that may persist for several seconds and may have profound consequences for the firing pattern of the neuron. Each component of the AHP is kinetically distinct and is mediated by different calcium-activated potassium channels. This gene belongs to the KCNN family of potassium channels. It encodes an integral membrane protein that forms a voltage-independent calcium-activated channel, which is thought to regulate neuronal excitability by contributing to the slow component of synaptic AHP. This gene contains two CAG repeat regions in the coding sequence. It was thought that expansion of one or both of these repeats could lead to an increased susceptibility to schizophrenia or bipolar disorder, but studies indicate that this is probably not the case. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2011]
KCNN3 Gene-Disease associations (from GenCC):
  • Zimmermann-Laband syndrome 3
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • Zimmermann-Laband syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • schizophrenia
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_002249.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.364 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002249.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNN3
NM_002249.6
MANE Select
c.934-19608C>G
intron
N/ANP_002240.3
KCNN3
NM_001204087.2
c.934-19608C>G
intron
N/ANP_001191016.1A0A087WYJ0
KCNN3
NM_001365837.1
c.-6-19608C>G
intron
N/ANP_001352766.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNN3
ENST00000271915.9
TSL:1 MANE Select
c.934-19608C>G
intron
N/AENSP00000271915.3Q9UGI6-1
KCNN3
ENST00000361147.8
TSL:1
c.18+17903C>G
intron
N/AENSP00000354764.4Q9UGI6-2
KCNN3
ENST00000358505.2
TSL:1
c.-6-19608C>G
intron
N/AENSP00000351295.2Q9UGI6-3

Frequencies

GnomAD3 genomes
AF:
0.298
AC:
45266
AN:
152034
Hom.:
7145
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.369
Gnomad AMI
AF:
0.288
Gnomad AMR
AF:
0.209
Gnomad ASJ
AF:
0.222
Gnomad EAS
AF:
0.0341
Gnomad SAS
AF:
0.205
Gnomad FIN
AF:
0.280
Gnomad MID
AF:
0.222
Gnomad NFE
AF:
0.309
Gnomad OTH
AF:
0.279
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.298
AC:
45329
AN:
152154
Hom.:
7161
Cov.:
32
AF XY:
0.293
AC XY:
21761
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.369
AC:
15298
AN:
41482
American (AMR)
AF:
0.208
AC:
3187
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.222
AC:
770
AN:
3472
East Asian (EAS)
AF:
0.0337
AC:
175
AN:
5186
South Asian (SAS)
AF:
0.205
AC:
987
AN:
4818
European-Finnish (FIN)
AF:
0.280
AC:
2962
AN:
10594
Middle Eastern (MID)
AF:
0.228
AC:
67
AN:
294
European-Non Finnish (NFE)
AF:
0.309
AC:
21016
AN:
67996
Other (OTH)
AF:
0.286
AC:
604
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1627
3254
4882
6509
8136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
450
900
1350
1800
2250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.295
Hom.:
3889
Bravo
AF:
0.293
Asia WGS
AF:
0.199
AC:
690
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.90
DANN
Benign
0.31
PhyloP100
-0.56
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs6666258;
hg19: chr1-154814268;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.